Adding calcium to EDTA plasma samples prior to analysis could solve the compatibility issue in commercially available ELISAs that are standardized for serum

Articles in the same Issue

1. Masthead
2. Masthead
3. Editorials
4. Biomarkers in the treatment of cancer: opportunities and pitfalls
5. Multicenter reference intervals studies: a promising perspective for the future?
6. Hemolysis-resistant reagent: another part of the puzzle for preventing errors in laboratory testing
7. Review
8. Exhaled breath condensate: a comprehensive update
9. Mini Review
10. Psoriasis, a new challenge for laboratory medicine
11. Opinion Paper
12. CA 19-9: handle with care
13. General Clinical Chemistry and Laboratory Medicine
14. Performance evaluation of human cytokines profiles obtained by various multiplexed-based technologies underlines a need for standardization
15. The iron regulatory hormone hepcidin is decreased in pregnancy: a prospective longitudinal study
16. Red blood cell distribution width is a potential prognostic index for liver disease
17. Development of a novel, hemolysis-resistant reagent for assessment of α-amylase in biological fluids
18. Performance of cassette-based blood gas analyzers to monitor blood glucose and lactate levels in a surgical intensive care setting
19. Reference Values and Biological Variations
20. The Asian project for collaborative derivation of reference intervals: (1) strategy and major results of standardized analytes
21. The Asian project for collaborative derivation of reference intervals: (2) results of non-standardized analytes and transference of reference intervals to the participating laboratories on the basis of cross-comparison of test results
22. Cancer Diagnostics
23. Study of an elevated carbohydrate antigen 19-9 concentration in a large health check-up cohort in China
24. Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids
25. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules
26. Serum HER-2 predicts response and resistance to trastuzumab treatment in breast cancer
27. Elevated tumor markers in patients with pulmonary alveolar proteinosis
28. Serum carcinoembryonic antigen is associated with non-alcoholic fatty liver disease in healthy Korean non-smokers
29. Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival
30. Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer
31. Cardiovascular Diseases
32. Association of nucleotide-binding oligomerization domain-like receptor 3 inflammasome and adverse clinical outcomes in patients with idiopathic dilated cardiomyopathy
33. Diabetes
34. α₁-Microglobulin/albumin ratio may improve interpretation of albuminuria in statin-treated patients
35. Infectious Diseases
36. The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: a prospective observational study
37. Letters to the Editor
38. Carryover does not affect results of Beckman Coulter highly-sensitive-AccuTnI assay on Access 2
39. Adding calcium to EDTA plasma samples prior to analysis could solve the compatibility issue in commercially available ELISAs that are standardized for serum
40. Interference of luteinizing hormone in the urinary point-of-care human chorionic gonadotropin test
41. Standardize the serum albumin assay now: calibrate it to 60% of the serum total protein assay
42. Interference of M-paraprotein in automated urea assays
43. A case of mistaken diagnosis of heparin-induced thrombocytopenia due to pseudothrombocytopenia
44. Delta check: a must in the management of hyponatremia
45. A novel cost effective algorithm for antinuclear antibody (ANA) testing in an outpatient setting